ArticleRheumatology international2015

Cost-utility analysis of tocilizumab monotherapy in first line versus standard of care for the treatment of rheumatoid arthritis in Greece.

Kostas Athanasakis et al.PubMed ↗Publisher ↗

No numbers read from the abstract.